Agarikonthe reference layer for psychedelic medicine
Blog Methodology Open the index
About

The reference layer for psychedelic medicine

Agarikon indexes 8,597 treatment and trial records — clinics, trial sites, registered studies and retreat centers — alongside 32,289 papers, 9,100 researchers and authors, 1,537 state bills and 167 industry organizations. 6,947 of those four carry coordinates and sit on the map; the 1,604 registered studies, like the papers, are indexed and filterable but have no single location to plot. Across everything we index, 7,113 records are on the map, and every record links to the public source it came from. It exists because this information was scattered across state registers, a federal trial database and several hundred operator websites, and nobody had put it in one place you could filter.

2,248clinics
4,528trial sites
1,604registered studies
217retreat centers

What it's for

Three groups get real use out of it. People looking for treatment, who need to know what's lawful and bookable where they live rather than what's promising in general. Researchers and journalists, who need counts they can cite and a way to see the field's actual shape. And operators, who mostly want to know what else exists in their state.

The design bet is that provenance beats polish. Every record carries a link back to its source, so you can check us in one click. The stamp in every page footer is the date those counts were computed, and /data shows when each source behind them was last read.

The legal basis field

This is the piece that doesn't exist anywhere else. Where a center publishes one, we record the statute, license or exemption it says it works under: Oregon's ORS 475A, Colorado's numbered NMHC license, a Health Canada section 56 exemption. Where an operator publishes nothing specific, we record what the country's law says about that substance, and only when we've read it in a statute, regulator or gazette page (26 such lines so far, each dated); the record says which kind of line it carries, because a country's law and an operator's own citation are different strengths of evidence. Where neither exists the record carries no basis line at all, only its legal-status class. 103 of 217 retreat records and 107 of 2,248 clinic records carry one today.

72countries
7.1kmapped
Nov 18build
The live index
8,597 treatment and trial records across 72 countries The map is the product: 7,113 geocoded records across every category, filterable by substance, country and legal status. Studies and papers are index-only — open any record for its source. Explore the map →

What it isn't

Not medical advice, not a booking service, and not an endorsement of anything listed. A record's presence means we found it in a public source, nothing more. 109 retreat listings carry nothing on the law but their own description, which the index labels “directory claim”, and they're listed so you can see that before you book.

We take no payment from operators for inclusion, placement or removal. There is no premium listing.

About the founder

Erich Mayne, founder of Agarikon

I’m the founder of Agarikon, and I build infrastructure for a living. Before that, I spent two years answering 911 calls as an EMT in Maryland and a year running ground operations for the state’s mobile COVID-19 vaccination program. Today, I work as a U.S. Army Reserve cyber operations specialist and infrastructure engineer in Seattle.

Those experiences shaped how I think about the next major shift in healthcare. I’ve seen firsthand how difficult it can be to connect people with effective mental-health care, and I believe we’re approaching a fundamental change in how those conditions are treated. Psychedelic medicine has the potential to be one of the most important parts of that transformation.

But new medical fields can’t mature on promising science alone. They need reliable infrastructure, transparent data, and a shared understanding of what has actually been studied.

That’s why I built Agarikon.

My goal is to help build the data infrastructure for the coming mental-health revolution: a centralized, continuously updated corpus of information on psychedelic therapies, their research, development, clinical trials, companies, compounds, and the broader ecosystem around them.

Agarikon rebuilds itself daily and traces every claim back to its source. The idea is simple: as this field develops, there should be a place where the entire body of knowledge can be organized, connected, and understood.

— Erich Mayne

Start here

Is psilocybin legal where I live is the most-used page. What you can book now covers availability by medicine and state. Recruiting trials lists who's enrolling now. And the methodology explains how all of it is built, including where it's weakest.